Gotowa bibliografia na temat „Respiratory agents”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Respiratory agents”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Respiratory agents"
Prince, Gregory A. "Respiratory syncytial virus antiviral agents". Expert Opinion on Therapeutic Patents 9, nr 6 (czerwiec 1999): 753–62. http://dx.doi.org/10.1517/13543776.9.6.753.
Pełny tekst źródłaSTEELE, RUSSELL W. "Antiviral agents for respiratory infections". Pediatric Infectious Disease Journal 7, nr 6 (czerwiec 1988): 457. http://dx.doi.org/10.1097/00006454-198806000-00036.
Pełny tekst źródłaTunevall, G., M. Ohlson, A. Svedmyr, G. Zeipel, Å. Frisk, P. Hedlund, B. Lamberger i H. Jernelius. "Aetiologic Agents in Respiratory Illness". Acta Medica Scandinavica 174, nr 2 (24.04.2009): 237–48. http://dx.doi.org/10.1111/j.0954-6820.1963.tb07917.x.
Pełny tekst źródłaTremblay, Cecile L. "Antiviral agents against respiratory viruses". Clinical Microbiology Newsletter 23, nr 21 (listopad 2001): 163–70. http://dx.doi.org/10.1016/s0196-4399(01)89050-4.
Pełny tekst źródłaWarden, Craig R. "Respiratory Agents: Irritant Gases, Riot Control Agents, Incapacitants, and Caustics". Critical Care Clinics 21, nr 4 (październik 2005): 719–37. http://dx.doi.org/10.1016/j.ccc.2005.05.008.
Pełny tekst źródłaS.H Torun, S. H. Torun, Ayper SOMER, Melis KANTURVARDAR, Selim BADUR, Nuran SALMAN i Ensar YEKELER. "Respiratory Viruses; Today’s Troubled Agents, Candidates for Marker of Diagnosis and Prognosis". Indian Journal of Applied Research 3, nr 10 (1.10.2011): 1–6. http://dx.doi.org/10.15373/2249555x/oct2013/102.
Pełny tekst źródłaChung, Moon-Hyun. "New Antimicrobial Agents in Respiratory Medicine". Tuberculosis and Respiratory Diseases 60, nr 1 (2006): 5. http://dx.doi.org/10.4046/trd.2006.60.1.5.
Pełny tekst źródła&NA;. "Surface active agents in respiratory disorders". Inpharma Weekly &NA;, nr 721 (styczeń 1990): 18–19. http://dx.doi.org/10.2165/00128413-199007210-00045.
Pełny tekst źródłaBrooks, Megan J., Joseph J. Sasadeusz i Gregory A. Tannock. "Antiviral chemotherapeutic agents against respiratory viruses". Current Opinion in Pulmonary Medicine 10, nr 3 (maj 2004): 197–203. http://dx.doi.org/10.1097/00063198-200405000-00009.
Pełny tekst źródłaAlshami, Abbas, Daryelle S. Varon i Joseph Varon. "Calpain Inhibitors: Promising Agents in Respiratory Medicine". Current Respiratory Medicine Reviews 14, nr 4 (1.02.2019): 187–88. http://dx.doi.org/10.2174/1573398x1404190126094459.
Pełny tekst źródłaRozprawy doktorskie na temat "Respiratory agents"
Marques, Gonçalo Nogueira. "Clinical approach to respiratory mucormycosis in a bottlenose dolphin (Tursiops truncatus) calf under human care". Master's thesis, Universidade de Lisboa, Faculdade de Medicina Veterinária, 2019. http://hdl.handle.net/10400.5/19336.
Pełny tekst źródłaSeveral fungi are described to cause invasive infections in dolphins, the respiratory system being a common site of involvement. Mucormycosis is considered one of the most devastating fungal infections in dolphins, associated with an elevated mortality rate, where hyphae are capable of invading blood vessels, producing tissue infarction and necrosis. A one-year-old male bottlenose dolphin (Tursiops truncatus) calf presented with a history of recurrent episodes of leukocytosis and occasional respiratory signs. During a routine faecal examination, a myriad of hyphae were found. Fungal culture revealed a mucormycete isolation, the aetiologic agent of mucormycosis. Molecular studies allowed to identify Cunninghamella bertholletiae. Thoracic radiographs showed the presence of a bronchoalveolar pattern on both the right and left lung apexes. A bronchoscopy was performed, which revealed multiple whitish lesions, diffusely distributed on the tracheal and bronchial submucosa. The antifungal therapy prescribed was a combination of posaconazole and aerosolized liposomal amphotericin B. Adjunctive therapies included bromhexine, vitamin C, vitamin B complex, probiotics, silymarin, Imuno-2865™ and ozone therapy. Follow-ups were conducted with haematology and blood biochemistry, faecal and sputum culture and direct microscopy, and bronchoscopies. There was a good overall response to treatment and antifungal therapy was discontinued. However, the infection relapsed and posaconazole therapy was restarted. Serum concentrations of posaconazole were retrospectively evaluated and the set of results did not appear to show subtherapeutic concentrations as a plausible explanation for the relapse. Although complete clinical resolution was not obtained during the timeframe considered, this case corroborates the idea that medical management of mucormycosis is possible, especially with a prompt diagnosis and treatment as well as a tight follow-up protocol. As described in the literature, mucormycosis treatment may take several years and relapses are common.
RESUMO - Maneio médico de mucormicose respiratória numa cria de golfinho-roaz (Tursiops truncatus) em contexto zoológico - Várias espécies de fungos estão descritas como agentes etiológicos de infeções invasivas em golfinhos, sendo o sistema respiratório um dos locais comuns de infeção. A mucormicose é uma das infeções fúngicas invasivas com efeitos mais devastadores, associada a uma elevada taxa de mortalidade em cetáceos. Nesta dissertação é apresentado um caso clínico referente a uma cria de golfinho-roaz (Tursiops truncatus) com um ano de idade, com uma história clínica que incluía episódios recorrentes de leucocitose e ocasionais sinais clínicos de etiologia respiratória. Como parte do programa de medicina preventiva instituído, uma análise microscópica de fezes permitiu a visualização de estruturas fúngicas. A cultura fúngica permitiu o isolamento de um mucormicete, o agente etiológico da mucormicose, e através de PCR e sequenciação foi possível identificar Cunninghamella bertholletiae. Estudos imagiológicos demonstraram a presença de um ligeiro padrão broncoalveolar nos ápices pulmonares e o exame endoscópico permitiu visualizar múltiplas lesões esbranquiçadas, difusamente distribuídas pelas mucosas traqueal e brônquica. O tratamento antifúngico consistiu na administração de comprimidos gastrorresistentes de posaconazol e nebulizações com anfotericina B lipossómica. Tratamentos adjuvantes incluíram bromexina, silimarina, suplementação vitamínica, probióticos, Imuno-2865TM e ozonoterapia. O acompanhamento do caso foi feito com base em dados hematológicos e bioquímicos, análises microscópicas/cultura de fezes e exsudado respiratório e broncoscopias. O tratamento com posaconazol foi descontinuado após 95 dias de terapia, tendo em conta os resultados constantemente negativos na cultura e observação microscópica de amostras fecais e exsudado respiratório. No entanto, verificou-se a recidiva da infeção e o tratamento antifúngico foi recomeçado. As concentrações séricas do fármaco ao longo do caso clínico foram retrospetivamente analisadas e esta monitorização permitiu descartar a hipótese de não terem sido atingidas concentrações séricas terapêuticas como causa da recidiva da infeção. Apesar de não ter existido uma completa resolução clínica no período considerado, este caso corrobora o facto do maneio médico da mucormicose em cetáceos ser possível, através de um diagnóstico e tratamento precoces, além de um plano apertado de seguimento clínico. Como descrito na bibliografia, o tratamento da mucormicose pode demorar vários anos e recidivas são comuns.
N/A
Tischer, Christina, Jan-Paul Zock, Maria Valkonen, Gert Doekes, Stefano Guerra, Dick Heederik, Deborah Jarvis i in. "Predictors of microbial agents in dust and respiratory health in the Ecrhs". BioMed Central Ltd, 2015. http://hdl.handle.net/10150/610304.
Pełny tekst źródłaFlorÃncio, Caroline Mary Gurgel Dias. "Nosocomial infection Childhood:he importance of respiratory viruses as agents of these diseases". Universidade Federal do CearÃ, 2014. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=12835.
Pełny tekst źródłaNosocomial infections (NI) are a serious public health problem. Knowledge about the etiology of NI is important for the development of control measures, prevention and treatment. Viruses are important etiologic agent of NI has been studied in populations considered at risk as premature, heart disease, lung disease, and immunosuppressed. Respiratory hospital infection (RHI) generate discomfort to patients, postponing medical interventions, postoperative complications, use more drugs and, in some cases, intensive care, may progress to cure or to death. Viruses are responsible for outbreaks of RHI in wards and intensive care units, with the virus as detected respiratory syncytial virus. In our country there are few data on the impact of RHI caused by respiratory viruses in children. Aims of the study were: identify and describe RHI cases in children and submit nasopharyngeal aspirates collected from January to December 2013 to search for molecular diagnosis 13 respiratory viruses [respiratory syncytial virus (RSV), adenovirus, influenza A and B, parainfluenza virus -1 ,-2 , -3 and -4 , metapneumovirus and human coronavirus OC43 , NL63 , 229E and HKU - 1]. During the study period, 120 samples were included in the study and 65 % were positive for at least one virus. A total of 114 viruses were detected (33 RSV, 32 adenovirus, 14 Parainfluenza -3, 14 influenza A , 12 Parainfluenza -4 , 5 parainfluenza -1 , 3 metapneumovirus and 1 coronavirus OC43). Co-detections occurred in 26 cases: 16 with two viruses and 10 with three viruses. No clinical differences between positive and negative RHI for viruses investigated were observed. Respiratory virus were detected in four of five deaths (5/120 4.16%) associated RHI. The knowledge about the occurrence of viral RHI in association with the period of viruses circulation in the community, as described in the study, allows to develop specific actions steps to prevent and control hospital outbreaks caused by viruses.
As infecÃÃes relacionadas à assistÃncia à saÃde (IRAS) sÃo um sÃrio problema de saÃde pÃblica. O conhecimento sobre a etiologia das IRAS à importante para o desenvolvimento de medidas de controle, prevenÃÃo e tratamento. A importÃncia dos vÃrus na etiologia das IRAS tem sido estudada em populaÃÃes consideradas de risco, como prematuros, cardiopatas, pneumopatas e imunodeprimidos. As infecÃÃes respiratÃrias hospitalares (IRH) geram aos pacientes desconforto, adiamento de intervenÃÃes mÃdicas, complicaÃÃes pÃs-cirÃrgicas, uso adicional de medicamentos e, em alguns casos, cuidados intensivos, podendo cursar para a cura ou para o Ãbito. Os vÃrus sÃo responsÃveis por surtos de IRH em enfermarias e unidades de terapia intensiva, sendo o vÃrus sincicial respiratÃrio o mais detectado. Em nosso paÃs sÃo escassos os dados sobre o impacto das IRH causadas por vÃrus respiratÃrios em pediatria. Os objetivos deste estudo foram: identificar e descrever os casos de IRH em crianÃas e submeter aspirados de nasofaringe coletados no perÃodo de janeiro a dezembro de 2013 ao diagnÃstico molecular para pesquisa de 13 vÃrus respiratÃrios [vÃrus sincicial respiratÃrio (VSR), adenovÃrus, influenza A e B, parainfluenza 1, 2, 3 e 4, metapneumovÃrus e coronavÃrus humanos OC43, NL63, 229E e HKU-1]. Para tanto, as amostras foram extraÃdas para obtenÃÃo do material genÃtico viral e, posteriormente, para os vÃrus de RNA, parte deste produto foi transformada em DNA complementar e depois a amplificado. Para detecÃÃo do adenovÃrus, foram realizados PCR e Nested PCR. No perÃodo de estudo, 120 amostras foram incluÃdas e 65% delas foram positivas para pelo menos um vÃrus. Um total de 114 vÃrus foram detectados (33 VSR; 32 adenovÃrus; 14 parainfluenza-3; 14 influenza A; 12 parainfluenza-4; 5 parainfluenza-1; 3 metapneumovÃrus e 1 coronavÃrus OC43). Co-detecÃÃes ocorreram em 26 casos: 16 com dois vÃrus e 10 com trÃs vÃrus. NÃo foram observadas diferenÃas clÃnicas entre as IRH positivas e negativas para os vÃrus pesquisados. VÃrus respiratÃrios foram identificados em quatro dos cinco casos de Ãbito (4,16%; 5/120) associados à IRH. O conhecimento sobre a ocorrÃncia da IRH virais em associaÃÃo com o perÃodo de circulaÃÃo dos vÃrus na comunidade, como descrito no estudo, permite desenvolver aÃÃes especÃficas de medidas para prevenir e controlar surtos hospitalares causados pelos vÃrus.
Du, Lanying. "Functional study of the spike protein of severe acute respiratory syndrome coronavirus". Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/B38602362.
Pełny tekst źródłaDu, Lanying, i 杜蘭英. "Functional study of the spike protein of severe acute respiratory syndrome coronavirus". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B38602362.
Pełny tekst źródłaZhang, Ke, i 张科. "Evaluation of anti-human respiratory syncytial virus effects of short interfering RNAs and β-defensin-4". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/209570.
Pełny tekst źródłapublished_or_final_version
Microbiology
Doctoral
Doctor of Philosophy
Sethi, Sumanjit Kaur. "Rhinovirus infection of airway epithelial cells : focus on the major group receptor, intercellular adhesion molecule-1 (ICAM-1), and its regulation". Thesis, Keele University, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.242449.
Pełny tekst źródłaYang, Li. "Studies on the effects of pharmacological agents on endotoxin induced pulmonary injury". Thesis, University of Hawaii at Manoa, 2003. http://proquest.umi.com/pqdweb?index=2&did=764805101&SrchMode=2&sid=10&Fmt=2&VInst=PROD&VType=PQD&RQT=309&VName=PQD&TS=1233179468&clientId=23440.
Pełny tekst źródłaPham, Nhu-An. "Generation of oxidative stress by the respiratory chain following treatment with DNA damaging agents". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0003/MQ46064.pdf.
Pełny tekst źródłaSans, Serramitjana Eulàlia. "Nanoencapsulated antimicrobials to fight Pseudomonas aeruginosa respiratory infections in cystic fibrosis patients: a promising strategy". Doctoral thesis, Universitat de Barcelona, 2017. http://hdl.handle.net/10803/461914.
Pełny tekst źródłaP.aeruginosa és un dels principals patògens oportunistes colonitzadors del tracte respiratori dels pacients amb fibrosi quística (FQ) causant una infecció crònica. Una vegada aquest microorganisme ja està establert de manera crònica al pulmó, la densitat bacteriana augmenta i P.aeruginosa canvia de morfologia no mucosa a mucosa afavorint la formació de biofilm en el qual la susceptibilitat als antibiòtics es veu enormement disminuïda. L’elevada resistència de P.aeruginosa a múltiples antimicrobians ens condueix a un escenari on gairebé no hi ha opcions de tractament disponibles. En aquest sentit, la recerca en la introducció d’antimicrobians menys tòxics així com l’ús de noves formes farmacèutiques amb la capacitat de reduir la dosi, allargar els intervals d’administració així com reduir la toxicitat adquireix molta rellevància. Per tant, l’objectiu d’aquesta tesi va ser desenvolupar nanopartícules lipídiques (Solid Lipid Nanoparticles: SLN y Nanostructured Lipid Carriers: NLC) carregades amb colistina I també les partícules amb tobramicina, explorar la seva activitat antimicrobiana comparant-la amb la seva forma lliure contra soques clíniques de P.aeruginosa aïllades de pacients amb FQ, i investigar l’eficàcia d’aquestes noves nanoformulacions en l’eradicació dels biofilms ja que és un dels mecanismes més rellevants associat a les infeccions cròniques.
Książki na temat "Respiratory agents"
Irwin, Ziment, i Popa Valentin, red. Respiratory pharmacology. Philadelphia: Saunders, 1986.
Znajdź pełny tekst źródłaM, Cherniack Reuben, red. Drugs for the respiratory system. Orlando: Grune and Stratton, Inc., 1986.
Znajdź pełny tekst źródłaTattersfield, Anne E. Respiratory disease. London: Springer-Verlag, 1987.
Znajdź pełny tekst źródłaGardenhire, Douglas S. Rau's respiratory care pharmacology. Wyd. 7. St. Louis, Mo: Mosby Elsevier, 2008.
Znajdź pełny tekst źródłaS, Gardenhire Douglas, i Rau Joseph L, red. Rau's respiratory care phamacology. Wyd. 7. St. Louis, Mo: Mosby/Elsevier, 2008.
Znajdź pełny tekst źródłaL, Rau Joseph, red. Rau's respiratory care pharmacology. Wyd. 8. St. Louis, Mo: Elsevier/Mosby, 2012.
Znajdź pełny tekst źródłaMoini, Jahangir. Cardiopulmonary pharmacology for respiratory care. Sudbury, Mass: Jones & Bartlett Learning, 2012.
Znajdź pełny tekst źródłaBills, Georgine W. Principles of pharmacology for respiratory care. Wyd. 2. Albany: Delmar Publishers, 1997.
Znajdź pełny tekst źródłaStephen, Newman. Respiratory drug delivery: Essential theory and practice. Richmond, Virginia: Respiratory Drug Delivery Online, 2009.
Znajdź pełny tekst źródłaInc, Medical Data International, red. U.S. markets for respiratory care products. Irvine, Calif. (2 Park Palza, Suite 1200, Irvine 92614): Medical Data International, 1998.
Znajdź pełny tekst źródłaCzęści książek na temat "Respiratory agents"
Mamrack, Mark D. "Respiratory Agents". W Exercise and Sport Pharmacology, 145–68. Second edition. | New York, NY: Routledge, 2020.: Routledge, 2020. http://dx.doi.org/10.4324/9781003035381-9.
Pełny tekst źródłaKirschenbaum, Harold L., i Michelle M. Kalis. "Respiratory Agents". W The Pharmacy Practice Handbook of Medication Facts, 163–92. New York: Routledge, 2023. http://dx.doi.org/10.4324/9780429272783-4.
Pełny tekst źródłaBhatt-Mehta, Varsha, i Steven M. Donn. "Pharmacologic Agents". W Manual of Neonatal Respiratory Care, 487–97. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39839-6_59.
Pełny tekst źródłaBhatt-Mehta, Varsha, i Steven M. Donn. "Pharmacologic Agents". W Manual of Neonatal Respiratory Care, 455–67. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-2155-9_52.
Pełny tekst źródłaBhatt-Mehta, Varsha, i Steven M. Donn. "Pharmacologic Agents". W Manual of Neonatal Respiratory Care, 571–83. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-93997-7_59.
Pełny tekst źródłaHayden, Frederick G., i Mark R. Denison. "Antiviral Agents for SARS". W Severe Acute Respiratory Syndrome, 184–202. Oxford, UK: Blackwell Publishing Ltd, 2008. http://dx.doi.org/10.1002/9780470755952.ch20.
Pełny tekst źródłaPerret Pérez, Cecilia, i Marcela Ferrés Garrido. "Pneumonia Caused by Emerging Viral Agents". W Pediatric Respiratory Diseases, 335–41. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-26961-6_34.
Pełny tekst źródłaLehingue, Samuel, Sami Hraiech i Laurent Papazian. "Pharmacological Interventions: Neuromuscular Blocking Agents". W Acute Respiratory Distress Syndrome, 189–200. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-41852-0_12.
Pełny tekst źródłaPerret Pérez, Cecilia. "Study of Infectious Agents in Respiratory Diseases". W Pediatric Respiratory Diseases, 145–50. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-26961-6_14.
Pełny tekst źródłaJack, David B. "Pharmacokinetic data on respiratory agents". W Handbook of Clinical Pharmacokinetic Data, 119–24. London: Palgrave Macmillan UK, 1992. http://dx.doi.org/10.1007/978-1-349-22495-1_34.
Pełny tekst źródłaStreszczenia konferencji na temat "Respiratory agents"
Sano, A., H. Sano, O. Nishiyama, Y. Tohda i H. Matsumoto. "Long-term Effects of Biological Agents on Respiratory Function". W American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5380.
Pełny tekst źródłaLegband, Nathan, Jameel Feshitan, Mark Borden i Benjamin Terry. "Living Without Breathing: A Study in Extrapulmonary Respiration Using a Novel Oxygen Carrier". W ASME 2013 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/sbc2013-14735.
Pełny tekst źródłaHeibati, B., M. S. Jaakkola, T. K. Lajunen, I. Paciência, A. Karimi i J. J.K. Jaakkola. "Occupational exposure to cleaning agents and respiratory health in healthcare professionals". W ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2393.
Pełny tekst źródłaSands, M. "248. OSHA upate: Respiratory Protection Against TB and other Biological Agents". W AIHce 2005. AIHA, 2005. http://dx.doi.org/10.3320/1.2758609.
Pełny tekst źródłaSakwari, Gloria H., Simon HD Mamuya, Magne Bråtveit i Bente E. Moen. "S08-4 Agents in coffee dust as factors for respiratory health problems". W Occupational Health: Think Globally, Act Locally, EPICOH 2016, September 4–7, 2016, Barcelona, Spain. BMJ Publishing Group Ltd, 2016. http://dx.doi.org/10.1136/oemed-2016-103951.291.
Pełny tekst źródłaMorimoto, K., LM Yoshida, M. Suzuki, HT Nguyen, AD Dang, PE Kilgore, H. Yanai i K. Ariyoshi. "Viral Etiological Agents and Clinical Features of Childhood Acute Respiratory Infection in Vietnam." W American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5999.
Pełny tekst źródłaGoetz, R. L., E. C. Thompson i S. Krick. "A Case of Respiratory Failure in a Patient Receiving Multiple Immune-Modulatory Agents". W American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2474.
Pełny tekst źródłaТолмачева, Ю. П., Е. И. Борисова, Е. В. Дзюба, Л. В. Суханова, И. А. Небесных, И. А. Демьянович i К. А. Демьянович. "ASSESSMENT OF THE SEDATIVE EFFECT OF VARIOUS ANESTHETICS IN COREGONUS PELED (GMELIN, 1789) IN AQUACULTURE". W DEVELOPMENT AND MODERN PROBLEMS OF AQUACULTURE. ООО "ДГТУ-Принт" Адресс полиграфического предприятия 344003 пл Гагарина, зд. 1, 2023. http://dx.doi.org/10.23947/aquaculture.2023.129-137.
Pełny tekst źródłaBaniasadi, Shadi, Maryam Alehashem, Amirali Mahboobipour i Behrooz Farzanegan. "Clinically important drug interactions with anti-infective agents in critically ill patients with respiratory disorders". W ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa3727.
Pełny tekst źródłaDonina, Zhanna. "Nonsteroid anti-inflammatory agents depress inflammation-related respiratory disoders and hypoxia-induced mortality. Experimental model". W ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2758.
Pełny tekst źródłaRaporty organizacyjne na temat "Respiratory agents"
Li, Qu, Xue-Ping Ma, Alimujiang Simayi, Xiao-Li Wang i Gui-Ping Xu. Comparative efficacy of various pharmacologic treatments of alcohol withdrawal syndrome: A systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, grudzień 2021. http://dx.doi.org/10.37766/inplasy2021.12.0010.
Pełny tekst źródłaMalo-Sánchez, Diana Carolina. Estacionalidad y severidad de las temporadas de infección respiratoria aguda por Virus Sincitial Respiratorio en Colombia, 2013 a 2019. Instituto Nacional de Salud, styczeń 2021. http://dx.doi.org/10.33610/01229907.2021v3n1a4.
Pełny tekst źródłaDroby, Samir, Michael Wisniewski, Ron Porat i Dumitru Macarisin. Role of Reactive Oxygen Species (ROS) in Tritrophic Interactions in Postharvest Biocontrol Systems. United States Department of Agriculture, grudzień 2012. http://dx.doi.org/10.32747/2012.7594390.bard.
Pełny tekst źródłaSorensen, J. H. Expedient Respiratory and Physical Protection: Does a Wet Towel Work to Prevent Chemical Warfare Agent Vapor Infiltration? Office of Scientific and Technical Information (OSTI), sierpień 2002. http://dx.doi.org/10.2172/814423.
Pełny tekst źródłaMorgan, Daniel, Gordon Flake, William Gwinn i Crystal Johnson. NTP Research Report on Respiratory Tract Toxicity of the Flavoring Agent 2,3-Hexanedione in Mice Exposed by Inhalation. NIEHS, sierpień 2019. http://dx.doi.org/10.22427/ntp-rr-10.
Pełny tekst źródłaHout, Joseph J. O-Chlorobenzylidene Malononitrile (CS Riot Control Agent) Exposures and Associated Acute Respiratory Illnesses in a United States Army Basic Combat Training Cohort. Fort Belvoir, VA: Defense Technical Information Center, luty 2014. http://dx.doi.org/10.21236/ad1012835.
Pełny tekst źródłaCantarella, Javier, Florentino Márquez, Ana María Pinto Ayala, Alejandra Leal Vallejo, Manuel Rodríguez, Daniel Páez, Juan Pablo Ramos i in. Cómo promover el buen uso de la bicicleta: Exposición del ciclista en ámbito urbano: Diagnóstico y recomendaciones. Inter-American Development Bank, listopad 2017. http://dx.doi.org/10.18235/0006104.
Pełny tekst źródłaGelb, Jr., Jack, Yoram Weisman, Brian Ladman i Rosie Meir. Identification of Avian Infectious Brochitis Virus Variant Serotypes and Subtypes by PCR Product Cycle Sequencing for the Rational Selection of Effective Vaccines. United States Department of Agriculture, grudzień 2003. http://dx.doi.org/10.32747/2003.7586470.bard.
Pełny tekst źródłaRecommendations for the selection and use of respirators and protective clothing for protection against biological agents. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, kwiecień 2009. http://dx.doi.org/10.26616/nioshpub2009132.
Pełny tekst źródłaEvidence Update for Clinicians: Narrow- versus Broad-Spectrum Antibiotics for Common Infections in Children. Patient-Centered Outcomes Research Institute (PCORI), październik 2018. http://dx.doi.org/10.25302/eu5.2018.10.
Pełny tekst źródła